Market Place
Sourcing Support
Invagen Pharms`s Generics Linagliptin Receives Approval in US
03 Sep 2024 //
FDA
Lupin receives FDA tentative marketing approval for generic Trijardy XR tablets
09 Jul 2024 //
PHARMABIZ
Lupin Pharm`s Generic Empagliflozin Receives Tentative Approval in US
08 Jul 2024 //
FDA
USV Launches Liralin Range for Diverse Group of Type 2 Diabetes Patients
04 Sep 2023 //
MEDICAL DIALOGUES
Lupin acquires two diabetes brands from Boehringer Ingelheim
19 Aug 2023 //
ECONOMIC TIMES
Sun`s Generic Empagliflozin, Linagliptin Receives Approval in the U.S.
12 Jun 2023 //
FDA
Zydus` Generic Linagliptin Receives Approval in the U.S.
30 Mar 2023 //
FDA
Torrent enters into co-marketing partnership with Boehringer Ingelheim India
15 Dec 2022 //
INDIANPHARMAPOST
PIII trial demonstrated Jardiance show reduction in blood sugar
07 Dec 2022 //
BUSINESSWIRE
Pricing authority caps rates of key diabetes drugs
25 Aug 2022 //
ECONOMIC TIMES
Alkem`s Generic Empagliflozin, Linagliptin Receives Approval in the U.S.
09 Aug 2022 //
FDA
Sunshine`s Generic Linagliptin Receives Approval in the US
31 Aug 2021 //
FDA
Sunshine`s Generic Linagliptin & Metformin HCl Receives Approval in the US
30 Aug 2021 //
FDA
Dr. Reddy`s Labo`s Generic Linagliptin;Metformin HCl Receives Approval In US
06 Feb 2021 //
FDA
Zydus Cadila gets tentative nod from USFDA to market diabetes drug
29 Oct 2020 //
ECONOMICTIMES
Lupin gets tentative nod for Empagliflozin and Linagliptin tablets
23 Jul 2020 //
BUSINESS-STANDARD
MSN Labs Generic Empagliflozin;Linagliptin Receives Approval In US
10 Jul 2020 //
FDA
FDA fast-tracks BI, Lilly`s Jardiance in chronic heart failure
26 Jun 2019 //
FIERCE PHARMA
Lilly, Boehringer`s DPP-4 drug Tradjenta ties rival in heart safety study
11 Jun 2019 //
FIERCE PHARMA
US FDA Accepts NDA for Triple Combination Tablet for Adults with Type 2 Diabetes
04 Jun 2019 //
PR NEWSWIRE
Jardiance sales ease Boehringer`s patent-loss pain
18 Apr 2019 //
FIERCE PHARMA
Zydus Pharms` Generic Linagliptin Receives Tentative Approval in US
05 Dec 2018 //
FDA
GLYXAMBI (empagliflozin/linagliptin) : Boehringer Ingelheim vs. Prinston Pharms
25 Nov 2018 //
PATENT LITIGATION
Jardiance (empagliflozin) : Boehringer Ingelheim vs. Annora Pharma
20 Nov 2018 //
PATENT LITIGATION
Jardiance (empagliflozin) & Glyxambi (empagliflozin/linagliptin) : Boehringer Ingelheim vs. Alkem Laboratories
07 Nov 2018 //
PATENT LITIGATION
Mylan`s Generic Linagliptin;Metformin HCl Receives Tentative Approval in US
03 Nov 2018 //
FDA
Zydus Cadila gets tentative USFDA nod for diabetes drug
11 Oct 2018 //
MONEY CONTROL
Zydus Cadila gets tentative USFDA nod for diabetes drug
11 Oct 2018 //
MONEY CONTROL
Zydus Cadila gets tentative USFDA nod for diabetes drug
11 Oct 2018 //
MONEY CONTROL
Boehringer Ingelheim & Lilly present results of Tradjenta`s CARMELINA® CV trial
06 Oct 2018 //
PR NEWSWIRE
PDL BioPharma Acquires Depomed`s Remaining 50% Interest in Royalties
02 Aug 2018 //
PR NEWSWIRE
BI, Lilly announce Trajenta’s cardiovascular outcome trial met primary endpoint
19 Jul 2018 //
BUSINESSWIRE
Lupin, Boehringer expand collaboration for co-marketing of anti-diabetic drugs
10 Jul 2018 //
PHARMABIZ
Hec Pharm USA Generic Linagliptin Receives Approval In US
25 May 2018 //
FDA
Hec Pharm USA Generic Linagliptin;Metformin HCL Receives Approval In US
22 May 2018 //
FDA
MSN Lab’s Generic Linagliptin Receives Approval In US
25 Oct 2017 //
FDA
Accord’s Generic Linagliptin;Metformin Hydrochloride Receives Approval In US
19 Oct 2017 //
FDA
Teva Pharm’s Generic Linagliptin Receives Tentative Approval In US
14 Sep 2017 //
FDA
Aurobindo Pharma’s Generic Linagliptin Receives Approval In US
20 Jun 2017 //
FDA
Boehringer Ingelheim and Lilly Diabetes Alliance to Present 33 Abstracts at ADA
09 Jun 2017 //
DDDMAG
Merck and Pfizer prep for battle with SGLT2, combo diabetes filings
14 Mar 2017 //
FIERCE PHARMA
AZ gets US approval for diabetes combo Qtern
01 Mar 2017 //
PMLIVE
AZ bounces back with diabetes combo win, but can it keep up with Lilly and BI?
28 Feb 2017 //
FIERCE PHARMA
US OKs CV Death Risk Reduction Data for Empagliflozin
06 Jan 2017 //
PHARMATIMES
Lily`s Jardiance Effective in Lowering Cardiovascular Death
15 Nov 2016 //
NASDAQ
Pharma already balks at Germany`s tough pricing regime
14 Nov 2016 //
FIERCE PHARMA
Eleven medicines leap towards EU approval
19 Sep 2016 //
PHARMATIMES
Merck`s DPP-4 newcomer Marizev trails Januvia in safety: Report
15 Apr 2016 //
FIERCE PHARMA
Lilly falls short of analyst forecasts with 2016 guidance on the `weaker end`
05 Jan 2016 //
FIERCE PHARMA
FDA Adds New Warnings on SGLT2 Inhibitors
04 Dec 2015 //
MEDPAGE TODAY
FDA warning on J&J`s Invokana adds more complexities to diabetes drug battles
12 Sep 2015 //
FIERCE PHARMA
FDA warns of severe joint pain risk with DPP-4 diabetes drugs
29 Aug 2015 //
REUTERS
Novo Nordisk becomes drug sales leader for metabolic drugs
17 Jun 2015 //
PM LIVE
